Products
- Lipid Lowering
- Cardio Vasculars
- Anti Bacterials
- Niche & Mass
- Anti Allergic
- Non Steroidal Anti Inflammatory
- Gastro Intestinal
- Anti Diabetic
- Anti Depressant
- Analgesic Antipyretic
- Under Launch
Financials
- Yearly Report-2011
About Us
- About Us
- Expert Regulatory
- Investors
- Management
- Milestones
- NPI World Wide
- Our Vision & Mission
- Quality Policy
- Social Responsibility
NPI Launches DIOCLAV (Co-Amoxyclav) and SPECTROMAX (Clarithromycin)
On 20th Feb 2011, NPI launched its two Supernovas in a grand function held at Hotel Grand Hyatt, Muscat.
Over 130 Doctors across the Sultanate of Oman attended this event.
The eminent Internist from Royal Hospital, Dr Seif Al Abri of Royal Hospital presented the medical perspective of these two products to the guest doctors.
The Chairman, Dr Ghazi Al Zubaidi and the Director of the board, Ms Amal Bahwan graced the occasion with their presence.
With these two new additions to the existing range of Antibiotics, NPI is sure to grab the therapeutic segment by storm.
The NPI’s products launch has attracted media attention in Oman.




Sending...